SCHEMBL24985641

SCHEMBL24985641

COC(=O)c1nc(-c2ccc(OC(F)F)cc2)c(F)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.43
▸ RAB9A P51151 4/20 0.43
▸ SMN1; SMN2 Q16637 4/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ KMT2A Q03164 5/20 0.41
▸ MEN1 O00255 4/20 0.41
▸ LMNA P02545 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ GAA P10253 1/20 0.40
▸ AGTR1 P30556 2/20 0.40
▸ TLR9 Q9NR96 1/20 0.40
▸ POLB P06746 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ PKM P14618 1/20 0.38
▸ RCE1 Q9Y256 1/20 0.38
▸ GRM4 Q14833 1/20 0.38
▸ CRHR1 P34998 1/20 0.38
▸ P2RX7 Q99572 2/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ NR1I2 O75469 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30185318 1.00 MAPT (0.43) MAPTRAB9ASMN1; SMN2NPC1KMT2A
SCHEMBL24987028 0.88 KDM4E (0.46) MAPTRAB9ASMN1; SMN2NPC1KMT2A
SCHEMBL30185106 0.87 CRHR1 (0.48) MAPTRAB9ASMN1; SMN2NPC1KMT2A
SCHEMBL30185102 0.87 PTGES (0.42) MAPTRAB9ASMN1; SMN2NPC1KMT2A
SCHEMBL24984517 0.87 CRHR1 (0.48) MAPTRAB9ASMN1; SMN2NPC1KMT2A
SCHEMBL24984519 0.87 PTGES (0.42) MAPTRAB9ASMN1; SMN2NPC1KMT2A
SCHEMBL30185302 0.85 KDM4E (0.42) MAPTRAB9ASMN1; SMN2NPC1LMNA
SCHEMBL24985683 0.85 KDM4E (0.42) MAPTRAB9ASMN1; SMN2NPC1LMNA
SCHEMBL24985128 0.85 SMN1; SMN2 (0.46) MAPTRAB9ASMN1; SMN2NPC1KMT2A
SCHEMBL24985136 0.85 SMN1; SMN2 (0.46) MAPTRAB9ASMN1; SMN2NPC1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230017045-A1 PYRIDINE AND PYRIMIDINE CARBOXYLATE HERBICIDES AND METHODS OF USE THEREOF DOW AGROSCIENCES LLC (US) 2023-01-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230017045-A1 PYRIDINE AND PYRIMIDINE CARBOXYLATE HERBICIDES AND METHODS OF USE THEREOF PDXK, DPYD, DDT MAPT 3017/4885RAB9A 3865/4885SMN1; SMN2 3265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback